Can a weekly shot curb your cravings? study tests Long-Term effects on appetite
NCT ID NCT05548647
Summary
This study looked at how the FDA-approved weight-loss medication semaglutide affects people's appetite, food cravings, and eating behavior over a long period. For 72 weeks, 120 adults with obesity received either the medication or a placebo (inactive shot), along with diet and exercise counseling. Researchers measured how much people ate, their feelings of hunger and fullness, and their relationship with food to understand the drug's long-term effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Pennsylvania Center for Weight and Eating Disorders
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.